0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Human Augmentation in Healthcare - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-10W12489
Home | Market Reports | Health| Pharmacy
Global Human Augmentation in Healthcare Market Research Report 2022
BUY CHAPTERS

Human Augmentation in Healthcare - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10W12489
Report
December 2024
Pages:160
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Augmentation in Healthcare - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Human Augmentation in Healthcare - Market

Human Augmentation in Healthcare - Market

The global market for Human Augmentation in Healthcare was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Augmentation in Healthcare, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Augmentation in Healthcare by region & country, by Type, and by Application.
The Human Augmentation in Healthcare market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Augmentation in Healthcare.
Market Segmentation

Scope of Human Augmentation in Healthcare - Market Report

Report Metric Details
Report Name Human Augmentation in Healthcare - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
Segment by Application
  • General Medical
  • Military Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 20 Knots Plus Ltd (20KTS+), Abbott Laboratories, AbbVie Inc., Abiomed, Asahi Kasei Kuraray Medical Co. Ltd., Baxter International, Bionic Power, Boston Scientific Corporation, Cochlear Ltd., Edwards Lifesciences Corporation, Ekso Bionics Holdings Inc., ExoAtlet, LivaNova PLC, Lockheed Martin Corporation, Medtronic plc, Orthofix Holdings Inc., Ossur Corporate, Otto Bock HealthCare GmBH, RB3D, Retina Implant AG, Sarcos Corporation, Sonova Holding AG, Spring Active, SRI International, SynCardia Systems LLC, Zimmer Biomet Holdings
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Human Augmentation in Healthcare manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Human Augmentation in Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Human Augmentation in Healthcare in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Human Augmentation in Healthcare - Market report?

Ans: The main players in the Human Augmentation in Healthcare - Market are 20 Knots Plus Ltd (20KTS+), Abbott Laboratories, AbbVie Inc., Abiomed, Asahi Kasei Kuraray Medical Co. Ltd., Baxter International, Bionic Power, Boston Scientific Corporation, Cochlear Ltd., Edwards Lifesciences Corporation, Ekso Bionics Holdings Inc., ExoAtlet, LivaNova PLC, Lockheed Martin Corporation, Medtronic plc, Orthofix Holdings Inc., Ossur Corporate, Otto Bock HealthCare GmBH, RB3D, Retina Implant AG, Sarcos Corporation, Sonova Holding AG, Spring Active, SRI International, SynCardia Systems LLC, Zimmer Biomet Holdings

What are the Application segmentation covered in the Human Augmentation in Healthcare - Market report?

Ans: The Applications covered in the Human Augmentation in Healthcare - Market report are General Medical, Military Application

What are the Type segmentation covered in the Human Augmentation in Healthcare - Market report?

Ans: The Types covered in the Human Augmentation in Healthcare - Market report are Power Prosthetics, Artificial Organ, Exoskeletons, Others

Recommended Reports

Advanced Prosthetics

Surgical Technology

Healthcare Infrastructure

1 Market Overview
1.1 Human Augmentation in Healthcare Product Introduction
1.2 Global Human Augmentation in Healthcare Market Size Forecast
1.3 Human Augmentation in Healthcare Market Trends & Drivers
1.3.1 Human Augmentation in Healthcare Industry Trends
1.3.2 Human Augmentation in Healthcare Market Drivers & Opportunity
1.3.3 Human Augmentation in Healthcare Market Challenges
1.3.4 Human Augmentation in Healthcare Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Augmentation in Healthcare Players Revenue Ranking (2023)
2.2 Global Human Augmentation in Healthcare Revenue by Company (2019-2024)
2.3 Key Companies Human Augmentation in Healthcare Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Augmentation in Healthcare Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Augmentation in Healthcare
2.6 Human Augmentation in Healthcare Market Competitive Analysis
2.6.1 Human Augmentation in Healthcare Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Human Augmentation in Healthcare Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Augmentation in Healthcare as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Power Prosthetics
3.1.2 Artificial Organ
3.1.3 Exoskeletons
3.1.4 Others
3.2 Global Human Augmentation in Healthcare Sales Value by Type
3.2.1 Global Human Augmentation in Healthcare Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Augmentation in Healthcare Sales Value, by Type (2019-2030)
3.2.3 Global Human Augmentation in Healthcare Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 General Medical
4.1.2 Military Application
4.2 Global Human Augmentation in Healthcare Sales Value by Application
4.2.1 Global Human Augmentation in Healthcare Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Augmentation in Healthcare Sales Value, by Application (2019-2030)
4.2.3 Global Human Augmentation in Healthcare Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Human Augmentation in Healthcare Sales Value by Region
5.1.1 Global Human Augmentation in Healthcare Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Augmentation in Healthcare Sales Value by Region (2019-2024)
5.1.3 Global Human Augmentation in Healthcare Sales Value by Region (2025-2030)
5.1.4 Global Human Augmentation in Healthcare Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Human Augmentation in Healthcare Sales Value, 2019-2030
5.2.2 North America Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Human Augmentation in Healthcare Sales Value, 2019-2030
5.3.2 Europe Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Human Augmentation in Healthcare Sales Value, 2019-2030
5.4.2 Asia Pacific Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Human Augmentation in Healthcare Sales Value, 2019-2030
5.5.2 South America Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Augmentation in Healthcare Sales Value, 2019-2030
5.6.2 Middle East & Africa Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Augmentation in Healthcare Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Augmentation in Healthcare Sales Value
6.3 United States
6.3.1 United States Human Augmentation in Healthcare Sales Value, 2019-2030
6.3.2 United States Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Augmentation in Healthcare Sales Value, 2019-2030
6.4.2 Europe Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Augmentation in Healthcare Sales Value, 2019-2030
6.5.2 China Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Augmentation in Healthcare Sales Value, 2019-2030
6.6.2 Japan Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Augmentation in Healthcare Sales Value, 2019-2030
6.7.2 South Korea Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Augmentation in Healthcare Sales Value, 2019-2030
6.8.2 Southeast Asia Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Augmentation in Healthcare Sales Value, 2019-2030
6.9.2 India Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Augmentation in Healthcare Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 20 Knots Plus Ltd (20KTS+)
7.1.1 20 Knots Plus Ltd (20KTS+) Profile
7.1.2 20 Knots Plus Ltd (20KTS+) Main Business
7.1.3 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Products, Services and Solutions
7.1.4 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.1.5 20 Knots Plus Ltd (20KTS+) Recent Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Profile
7.2.2 Abbott Laboratories Main Business
7.2.3 Abbott Laboratories Human Augmentation in Healthcare Products, Services and Solutions
7.2.4 Abbott Laboratories Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Laboratories Recent Developments
7.3 AbbVie Inc.
7.3.1 AbbVie Inc. Profile
7.3.2 AbbVie Inc. Main Business
7.3.3 AbbVie Inc. Human Augmentation in Healthcare Products, Services and Solutions
7.3.4 AbbVie Inc. Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.3.5 Abiomed Recent Developments
7.4 Abiomed
7.4.1 Abiomed Profile
7.4.2 Abiomed Main Business
7.4.3 Abiomed Human Augmentation in Healthcare Products, Services and Solutions
7.4.4 Abiomed Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.4.5 Abiomed Recent Developments
7.5 Asahi Kasei Kuraray Medical Co. Ltd.
7.5.1 Asahi Kasei Kuraray Medical Co. Ltd. Profile
7.5.2 Asahi Kasei Kuraray Medical Co. Ltd. Main Business
7.5.3 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Products, Services and Solutions
7.5.4 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.5.5 Asahi Kasei Kuraray Medical Co. Ltd. Recent Developments
7.6 Baxter International
7.6.1 Baxter International Profile
7.6.2 Baxter International Main Business
7.6.3 Baxter International Human Augmentation in Healthcare Products, Services and Solutions
7.6.4 Baxter International Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.6.5 Baxter International Recent Developments
7.7 Bionic Power
7.7.1 Bionic Power Profile
7.7.2 Bionic Power Main Business
7.7.3 Bionic Power Human Augmentation in Healthcare Products, Services and Solutions
7.7.4 Bionic Power Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.7.5 Bionic Power Recent Developments
7.8 Boston Scientific Corporation
7.8.1 Boston Scientific Corporation Profile
7.8.2 Boston Scientific Corporation Main Business
7.8.3 Boston Scientific Corporation Human Augmentation in Healthcare Products, Services and Solutions
7.8.4 Boston Scientific Corporation Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.8.5 Boston Scientific Corporation Recent Developments
7.9 Cochlear Ltd.
7.9.1 Cochlear Ltd. Profile
7.9.2 Cochlear Ltd. Main Business
7.9.3 Cochlear Ltd. Human Augmentation in Healthcare Products, Services and Solutions
7.9.4 Cochlear Ltd. Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.9.5 Cochlear Ltd. Recent Developments
7.10 Edwards Lifesciences Corporation
7.10.1 Edwards Lifesciences Corporation Profile
7.10.2 Edwards Lifesciences Corporation Main Business
7.10.3 Edwards Lifesciences Corporation Human Augmentation in Healthcare Products, Services and Solutions
7.10.4 Edwards Lifesciences Corporation Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.10.5 Edwards Lifesciences Corporation Recent Developments
7.11 Ekso Bionics Holdings Inc.
7.11.1 Ekso Bionics Holdings Inc. Profile
7.11.2 Ekso Bionics Holdings Inc. Main Business
7.11.3 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Products, Services and Solutions
7.11.4 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.11.5 Ekso Bionics Holdings Inc. Recent Developments
7.12 ExoAtlet
7.12.1 ExoAtlet Profile
7.12.2 ExoAtlet Main Business
7.12.3 ExoAtlet Human Augmentation in Healthcare Products, Services and Solutions
7.12.4 ExoAtlet Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.12.5 ExoAtlet Recent Developments
7.13 LivaNova PLC
7.13.1 LivaNova PLC Profile
7.13.2 LivaNova PLC Main Business
7.13.3 LivaNova PLC Human Augmentation in Healthcare Products, Services and Solutions
7.13.4 LivaNova PLC Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.13.5 LivaNova PLC Recent Developments
7.14 Lockheed Martin Corporation
7.14.1 Lockheed Martin Corporation Profile
7.14.2 Lockheed Martin Corporation Main Business
7.14.3 Lockheed Martin Corporation Human Augmentation in Healthcare Products, Services and Solutions
7.14.4 Lockheed Martin Corporation Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.14.5 Lockheed Martin Corporation Recent Developments
7.15 Medtronic plc
7.15.1 Medtronic plc Profile
7.15.2 Medtronic plc Main Business
7.15.3 Medtronic plc Human Augmentation in Healthcare Products, Services and Solutions
7.15.4 Medtronic plc Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.15.5 Medtronic plc Recent Developments
7.16 Orthofix Holdings Inc.
7.16.1 Orthofix Holdings Inc. Profile
7.16.2 Orthofix Holdings Inc. Main Business
7.16.3 Orthofix Holdings Inc. Human Augmentation in Healthcare Products, Services and Solutions
7.16.4 Orthofix Holdings Inc. Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.16.5 Orthofix Holdings Inc. Recent Developments
7.17 Ossur Corporate
7.17.1 Ossur Corporate Profile
7.17.2 Ossur Corporate Main Business
7.17.3 Ossur Corporate Human Augmentation in Healthcare Products, Services and Solutions
7.17.4 Ossur Corporate Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.17.5 Ossur Corporate Recent Developments
7.18 Otto Bock HealthCare GmBH
7.18.1 Otto Bock HealthCare GmBH Profile
7.18.2 Otto Bock HealthCare GmBH Main Business
7.18.3 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Products, Services and Solutions
7.18.4 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.18.5 Otto Bock HealthCare GmBH Recent Developments
7.19 RB3D
7.19.1 RB3D Profile
7.19.2 RB3D Main Business
7.19.3 RB3D Human Augmentation in Healthcare Products, Services and Solutions
7.19.4 RB3D Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.19.5 RB3D Recent Developments
7.20 Retina Implant AG
7.20.1 Retina Implant AG Profile
7.20.2 Retina Implant AG Main Business
7.20.3 Retina Implant AG Human Augmentation in Healthcare Products, Services and Solutions
7.20.4 Retina Implant AG Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.20.5 Retina Implant AG Recent Developments
7.21 Sarcos Corporation
7.21.1 Sarcos Corporation Profile
7.21.2 Sarcos Corporation Main Business
7.21.3 Sarcos Corporation Human Augmentation in Healthcare Products, Services and Solutions
7.21.4 Sarcos Corporation Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.21.5 Sarcos Corporation Recent Developments
7.22 Sonova Holding AG
7.22.1 Sonova Holding AG Profile
7.22.2 Sonova Holding AG Main Business
7.22.3 Sonova Holding AG Human Augmentation in Healthcare Products, Services and Solutions
7.22.4 Sonova Holding AG Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.22.5 Sonova Holding AG Recent Developments
7.23 Spring Active
7.23.1 Spring Active Profile
7.23.2 Spring Active Main Business
7.23.3 Spring Active Human Augmentation in Healthcare Products, Services and Solutions
7.23.4 Spring Active Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.23.5 Spring Active Recent Developments
7.24 SRI International
7.24.1 SRI International Profile
7.24.2 SRI International Main Business
7.24.3 SRI International Human Augmentation in Healthcare Products, Services and Solutions
7.24.4 SRI International Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.24.5 SRI International Recent Developments
7.25 SynCardia Systems LLC
7.25.1 SynCardia Systems LLC Profile
7.25.2 SynCardia Systems LLC Main Business
7.25.3 SynCardia Systems LLC Human Augmentation in Healthcare Products, Services and Solutions
7.25.4 SynCardia Systems LLC Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.25.5 SynCardia Systems LLC Recent Developments
7.26 Zimmer Biomet Holdings
7.26.1 Zimmer Biomet Holdings Profile
7.26.2 Zimmer Biomet Holdings Main Business
7.26.3 Zimmer Biomet Holdings Human Augmentation in Healthcare Products, Services and Solutions
7.26.4 Zimmer Biomet Holdings Human Augmentation in Healthcare Revenue (US$ Million) & (2019-2024)
7.26.5 Zimmer Biomet Holdings Recent Developments
8 Industry Chain Analysis
8.1 Human Augmentation in Healthcare Industrial Chain
8.2 Human Augmentation in Healthcare Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Augmentation in Healthcare Sales Model
8.5.2 Sales Channel
8.5.3 Human Augmentation in Healthcare Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Human Augmentation in Healthcare Market Trends
    Table 2. Human Augmentation in Healthcare Market Drivers & Opportunity
    Table 3. Human Augmentation in Healthcare Market Challenges
    Table 4. Human Augmentation in Healthcare Market Restraints
    Table 5. Global Human Augmentation in Healthcare Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Human Augmentation in Healthcare Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Human Augmentation in Healthcare Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Human Augmentation in Healthcare Product Type
    Table 9. Key Companies Time to Begin Mass Production of Human Augmentation in Healthcare
    Table 10. Global Human Augmentation in Healthcare Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Augmentation in Healthcare as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Human Augmentation in Healthcare Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Human Augmentation in Healthcare Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Human Augmentation in Healthcare Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Human Augmentation in Healthcare Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Human Augmentation in Healthcare Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Human Augmentation in Healthcare Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Human Augmentation in Healthcare Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Human Augmentation in Healthcare Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Human Augmentation in Healthcare Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Human Augmentation in Healthcare Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Human Augmentation in Healthcare Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Human Augmentation in Healthcare Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Human Augmentation in Healthcare Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Human Augmentation in Healthcare Sales Value by Region (2019-2024) & (%)
    Table 27. Global Human Augmentation in Healthcare Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Human Augmentation in Healthcare Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Human Augmentation in Healthcare Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Human Augmentation in Healthcare Sales Value, (2025-2030) & (US$ Million)
    Table 31. 20 Knots Plus Ltd (20KTS+) Basic Information List
    Table 32. 20 Knots Plus Ltd (20KTS+) Description and Business Overview
    Table 33. 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Human Augmentation in Healthcare Business of 20 Knots Plus Ltd (20KTS+) (2019-2024)
    Table 35. 20 Knots Plus Ltd (20KTS+) Recent Developments
    Table 36. Abbott Laboratories Basic Information List
    Table 37. Abbott Laboratories Description and Business Overview
    Table 38. Abbott Laboratories Human Augmentation in Healthcare Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Abbott Laboratories (2019-2024)
    Table 40. Abbott Laboratories Recent Developments
    Table 41. AbbVie Inc. Basic Information List
    Table 42. AbbVie Inc. Description and Business Overview
    Table 43. AbbVie Inc. Human Augmentation in Healthcare Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Human Augmentation in Healthcare Business of AbbVie Inc. (2019-2024)
    Table 45. AbbVie Inc. Recent Developments
    Table 46. Abiomed Basic Information List
    Table 47. Abiomed Description and Business Overview
    Table 48. Abiomed Human Augmentation in Healthcare Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Abiomed (2019-2024)
    Table 50. Abiomed Recent Developments
    Table 51. Asahi Kasei Kuraray Medical Co. Ltd. Basic Information List
    Table 52. Asahi Kasei Kuraray Medical Co. Ltd. Description and Business Overview
    Table 53. Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Asahi Kasei Kuraray Medical Co. Ltd. (2019-2024)
    Table 55. Asahi Kasei Kuraray Medical Co. Ltd. Recent Developments
    Table 56. Baxter International Basic Information List
    Table 57. Baxter International Description and Business Overview
    Table 58. Baxter International Human Augmentation in Healthcare Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Baxter International (2019-2024)
    Table 60. Baxter International Recent Developments
    Table 61. Bionic Power Basic Information List
    Table 62. Bionic Power Description and Business Overview
    Table 63. Bionic Power Human Augmentation in Healthcare Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Bionic Power (2019-2024)
    Table 65. Bionic Power Recent Developments
    Table 66. Boston Scientific Corporation Basic Information List
    Table 67. Boston Scientific Corporation Description and Business Overview
    Table 68. Boston Scientific Corporation Human Augmentation in Healthcare Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Boston Scientific Corporation (2019-2024)
    Table 70. Boston Scientific Corporation Recent Developments
    Table 71. Cochlear Ltd. Basic Information List
    Table 72. Cochlear Ltd. Description and Business Overview
    Table 73. Cochlear Ltd. Human Augmentation in Healthcare Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Cochlear Ltd. (2019-2024)
    Table 75. Cochlear Ltd. Recent Developments
    Table 76. Edwards Lifesciences Corporation Basic Information List
    Table 77. Edwards Lifesciences Corporation Description and Business Overview
    Table 78. Edwards Lifesciences Corporation Human Augmentation in Healthcare Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Edwards Lifesciences Corporation (2019-2024)
    Table 80. Edwards Lifesciences Corporation Recent Developments
    Table 81. Ekso Bionics Holdings Inc. Basic Information List
    Table 82. Ekso Bionics Holdings Inc. Description and Business Overview
    Table 83. Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Ekso Bionics Holdings Inc. (2019-2024)
    Table 85. Ekso Bionics Holdings Inc. Recent Developments
    Table 86. ExoAtlet Basic Information List
    Table 87. ExoAtlet Description and Business Overview
    Table 88. ExoAtlet Human Augmentation in Healthcare Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Human Augmentation in Healthcare Business of ExoAtlet (2019-2024)
    Table 90. ExoAtlet Recent Developments
    Table 91. LivaNova PLC Basic Information List
    Table 92. LivaNova PLC Description and Business Overview
    Table 93. LivaNova PLC Human Augmentation in Healthcare Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Human Augmentation in Healthcare Business of LivaNova PLC (2019-2024)
    Table 95. LivaNova PLC Recent Developments
    Table 96. Lockheed Martin Corporation Basic Information List
    Table 97. Lockheed Martin Corporation Description and Business Overview
    Table 98. Lockheed Martin Corporation Human Augmentation in Healthcare Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Lockheed Martin Corporation (2019-2024)
    Table 100. Lockheed Martin Corporation Recent Developments
    Table 101. Medtronic plc Basic Information List
    Table 102. Medtronic plc Description and Business Overview
    Table 103. Medtronic plc Human Augmentation in Healthcare Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Medtronic plc (2019-2024)
    Table 105. Medtronic plc Recent Developments
    Table 106. Orthofix Holdings Inc. Basic Information List
    Table 107. Orthofix Holdings Inc. Description and Business Overview
    Table 108. Orthofix Holdings Inc. Human Augmentation in Healthcare Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Orthofix Holdings Inc. (2019-2024)
    Table 110. Orthofix Holdings Inc. Recent Developments
    Table 111. Ossur Corporate Basic Information List
    Table 112. Ossur Corporate Description and Business Overview
    Table 113. Ossur Corporate Human Augmentation in Healthcare Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Ossur Corporate (2019-2024)
    Table 115. Ossur Corporate Recent Developments
    Table 116. Otto Bock HealthCare GmBH Basic Information List
    Table 117. Otto Bock HealthCare GmBH Description and Business Overview
    Table 118. Otto Bock HealthCare GmBH Human Augmentation in Healthcare Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Otto Bock HealthCare GmBH (2019-2024)
    Table 120. Otto Bock HealthCare GmBH Recent Developments
    Table 121. RB3D Basic Information List
    Table 122. RB3D Description and Business Overview
    Table 123. RB3D Human Augmentation in Healthcare Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Human Augmentation in Healthcare Business of RB3D (2019-2024)
    Table 125. RB3D Recent Developments
    Table 126. Retina Implant AG Basic Information List
    Table 127. Retina Implant AG Description and Business Overview
    Table 128. Retina Implant AG Human Augmentation in Healthcare Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Retina Implant AG (2019-2024)
    Table 130. Retina Implant AG Recent Developments
    Table 131. Sarcos Corporation Basic Information List
    Table 132. Sarcos Corporation Description and Business Overview
    Table 133. Sarcos Corporation Human Augmentation in Healthcare Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Sarcos Corporation (2019-2024)
    Table 135. Sarcos Corporation Recent Developments
    Table 136. Sonova Holding AG Basic Information List
    Table 137. Sonova Holding AG Description and Business Overview
    Table 138. Sonova Holding AG Human Augmentation in Healthcare Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Sonova Holding AG (2019-2024)
    Table 140. Sonova Holding AG Recent Developments
    Table 141. Spring Active Basic Information List
    Table 142. Spring Active Description and Business Overview
    Table 143. Spring Active Human Augmentation in Healthcare Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Spring Active (2019-2024)
    Table 145. Spring Active Recent Developments
    Table 146. SRI International Basic Information List
    Table 147. SRI International Description and Business Overview
    Table 148. SRI International Human Augmentation in Healthcare Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Human Augmentation in Healthcare Business of SRI International (2019-2024)
    Table 150. SRI International Recent Developments
    Table 151. SynCardia Systems LLC Basic Information List
    Table 152. SynCardia Systems LLC Description and Business Overview
    Table 153. SynCardia Systems LLC Human Augmentation in Healthcare Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Human Augmentation in Healthcare Business of SynCardia Systems LLC (2019-2024)
    Table 155. SynCardia Systems LLC Recent Developments
    Table 156. Zimmer Biomet Holdings Basic Information List
    Table 157. Zimmer Biomet Holdings Description and Business Overview
    Table 158. Zimmer Biomet Holdings Human Augmentation in Healthcare Products, Services and Solutions
    Table 159. Revenue (US$ Million) in Human Augmentation in Healthcare Business of Zimmer Biomet Holdings (2019-2024)
    Table 160. Zimmer Biomet Holdings Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Human Augmentation in Healthcare Downstream Customers
    Table 164. Human Augmentation in Healthcare Distributors List
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
    Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Human Augmentation in Healthcare Product Picture
    Figure 2. Global Human Augmentation in Healthcare Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Human Augmentation in Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 4. Human Augmentation in Healthcare Report Years Considered
    Figure 5. Global Human Augmentation in Healthcare Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Augmentation in Healthcare Revenue in 2023
    Figure 7. Human Augmentation in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Power Prosthetics Picture
    Figure 9. Artificial Organ Picture
    Figure 10. Exoskeletons Picture
    Figure 11. Others Picture
    Figure 12. Global Human Augmentation in Healthcare Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Human Augmentation in Healthcare Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of General Medical
    Figure 15. Product Picture of Military Application
    Figure 16. Global Human Augmentation in Healthcare Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Human Augmentation in Healthcare Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Human Augmentation in Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Human Augmentation in Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Human Augmentation in Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Human Augmentation in Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Human Augmentation in Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Human Augmentation in Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Human Augmentation in Healthcare Sales Value (%), (2019-2030)
    Figure 29. United States Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Human Augmentation in Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Human Augmentation in Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Human Augmentation in Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 50. Human Augmentation in Healthcare Industrial Chain
    Figure 51. Human Augmentation in Healthcare Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart